Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Gabapentin NDC 50090-5045 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - image 01
This is a chart showing the mean pain score for individuals who participated in a study of two types of Parkinson's disease medication - one with a fixed dose, and one with titration. The chart also includes the results for a placebo group and a group taking Gabapentin at a dosage of 3600 mg/day. The data is shown for baseline and various time points up to four weeks.*
Figure 2 - image 02
This is a chart showing the results of a 4-week fixed dose period study on the effect of Gabapentin on pain. The graph shows the mean pain score over the course of the study. The study involved a placebo group and two Gabapentin groups, one taking 1800 mg/day and the other taking 2400 mg/day.*
Figure 3 - image 03
Cockcroft and Gault Equation - image 04
Gabapentin Structural Formula - image 05
Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09
Label Image - lbl500905045
This is a medication called Gabapentin available in tablet form in a bottle of 90 tablets. The dosage strength is 800 mg. The prescription label indicates that it should be stored at a temperature between 8 to 10 degrees Celsius and dispensed in 7 doses. The first two lines of the text are not coherent.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.